100th Annual Meeting of the American Urological Association

Mr. Alexander summarizes presentations on androgen-suppressing therapies for men with prostate cancer and the associated risk of osteoporosis, the use of bone scans in prostate cancer, and genetic mutations as markers for selecting pharmacotherapy.